Ranking results:

Past rankings:

2020
Criterium:	Position:
Overall Score:	600-700
Total Project Funding per Partner:	> 1000
Total Number of Projects:	500-600
2019
Criterium:	Position:
Overall Score:	200-300
Total Project Funding per Partner:	600-700
Total Number of Projects:	100-200

Ranking timeline:

Project Participation Performance(2019-01-01 - 2024-12-31 ):

Total Project Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:

Leadership:

Total number of projects: 41
As coordinator: 0
As participant: 41
Sole participant: 0
Coordinator / Participant Ratio: 0^*

^*Ratio includes only projects with > 2 partners

Summary:

	Total project funding [€]:			Projects [No]:
Year:	coordinator^*	participant^*	per partner	as coordinator	as participant
2023	0	9.139.200	0		2
2022	0	23.969.456	1.157.419		5
2021	0	47.126.100	2.076.622		10
2020	0	49.365.492	1.086.449		8
2019	0	170.536.767	3.310.038		16

^*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:

Institution:	Projects [No]:
BAYER	13
PFIZER LIMITED	13
NOVARTIS PHARMA	12
JANSSEN PHARMACEUTICA NV	11
SANOFIAVENTIS	11
F HOFFMANNLA ROCHE	10
KATHOLIEKE UNIVERSITEIT LEUVEN	9
KAROLINSKA INSTITUTE	7
UNIVERSITAIR MEDISCH CENTRUM UTRECHT	7
ABBVIE INC	6
TAKEDA PHARMACEUTICALS INTERNATIONAL	6
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD	6
UNIVERSITY COLLEGE LONDON	6
BOEHRINGER INGELHEIM PHARMA GMBH &CO KG	5
CHARITE UNIVERSITAETSMEDIZIN BERLIN	5
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM	5
GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT	5
IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE	5
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE	5
MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN	5
UCB BIOPHARMA	5
UNIVERSITAET ZUERICH	5
ACADEMIC MEDICAL CENTRE AMSTERDAM	4
FORUM DES PATIENTS EUROPEENS	4
KING'S COLLEGE LONDON	4
LEIDS UNIVERSITAIR MEDISCH CENTRUM	4
STICHTING LYGATURE	4
TAKEDA DEVELOPMENT CENTRE EUROPE	4
TEAM IT RESEARCH SL	4
TEVA PHARMACEUTICAL INDUSTRIES LIMITED	4
THE PROVOST FELLOWS AND SCHOLARS OF THE COLLEGE OF THE HOLY AND UNDIVIDED TRINITY OF QUEEN ELIZABETH NEAR DUBLIN HEREINAFTER TRINITY COLLEGE DUBLIN	4
THE UNIVERSITY OF MANCHESTER	4
UNIVERSITA VITASALUTE SAN RAFFAELE	4
UNIVERSITY OF COPENHAGEN	4
UNIVERSITY OF NEWCASTLE UPON TYNE	4
UPPSALA UNIVERSITET	4
ACADEMISCH ZIEKENHUIS GRONINGEN	3
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE	3
ELI LILLY AND COMPANY	3
FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E V	3
GSF FORSCHUNGSZENTRUM FUER UMWELT UND GESUNDHEIT	3
LEIDEN UNIVERSITY	3
LUND UNIVERSITY	3
MEDIZINISCHE UNIVERSITAET WIEN	3
MERCK SHARP & DOHME CORP	3
QUEEN MARY AND WESTFIELD COLLEGE UNIVERSITY OF LONDON	3
RISE RESEARCH INSTITUTES OF SWEDEN AB	3
SYDDANSK UNIVERSITET	3
THE EUROPEAN INSTITUTE FOR INNOVATION THROUGH HEALTH DATA	3
UNIVERSITAETSKLINIKUM FREIBURG	3
UNIVERSITAT WIEN	3
UNIVERSITEIT GENT	3
UNIVERSITEIT UTRECHT	3
UNIVERSITY COLLEGE DUBLIN	3
UNIVERSITY OF CAMBRIDGE	3
UNIVERSITY OF GLASGOW	3
UNIVERSITY OF TAMPERE	3
ACCADEMIA EUROPEA PER LA RICERCA APPLICATA ED IL PERFEZIONAMENTO PROFESSIONALE BOLZANO	2
ALLERGAN LIMITED	2
CHARLES RIVER DISCOVERY RESEARCH SERVICES GERMANY	2
CHRISTIAN ALBRECHTS UNIVERSITAET ZU KIEL	2
CLINIQUES UNIVERSITAIRES SAINTLUC	2
DREEM	2
DRESDEN UNIVERSITY OF TECHNOLOGY	2
EATRIS ERIC	2
ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE	2
ECRIN EUROPEAN CLINICAL RESEARCH INFRASTRUCTURE NETWORK	2
EIDGENOESSISCHE TECHNISCHE HOCHSCHULE ZUERICH	2
ELI LILLY AND COMPANY LIMITED	2
EMPIRICA GESELLSCHAFT FUR KOMMUNIKATIONS UND TECHNOLOGIEFORSCHUNG MBH	2
ETHNIKO KENTRO EREVNAS KAI TECHNOLOGIKIS ANAPTYXIS	2
EURICE EUROPEAN RESEARCH AND PROJECT OFFICE	2
EUROPEAN LUNG FOUNDATION	2
EUROPEAN RESPIRATORY SOCIETY	2
FRIEDRICHALEXANDERUNIVERSITAET ERLANGEN NUERNBERG	2
FUNDACIO PRIVADA CLINIC PER A LA RECERCA BIOMEDICA	2
FUNDACION PARA EL FOMENTO DE LA INVESTIGACION SANITARIA Y BIOMEDICA DE LA COMUNITAT VALENCIANA	2
GRUNENTHAL	2
HELSE STAVANGER HF	2
INSTITUT DE RECHERCHES INTERNATIONALES SERVIER IRIS	2
INSTITUT DE RECHERCHES SERVIER	2
INSTITUTE OF ORGANIC CHEMISTRY POLISH ACADEMY OF SCIENCES	2
INSTITUTO DE MEDICINA MOLECULAR JOAO LOBO ANTUNES	2
IXSCIENT LIMITED	2
LUDWIG MAXIMILIANS UNIVERSITAET MUENCHEN	2
MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH	2
MAX PLANCK GESELLSCHAFT ZUR FOERDERUNG DER WISSENSCHAFTEN EV	2
MCROBERTS BV	2
MDSOL EUROPE	2
MEDTRONIC INTERNATIONAL TRADING SARL	2
NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS	2
NORGES TEKNISKNATURVITENSKAPELIGE UNIVERSITET NTNU	2
NOVO NORDISK	2
OWKIN FRANCE	2
PARKINSON'S DISEASE SOCIETY OF THEUNITED KINGDOM LBG	2
REGION STOCKHOLM	2
RIJKSINSTITUUT VOOR VOLKSGEZONDHEID EN MILIEU	2
SERVICIO MADRILENO DE SALUD	2
STICHTING HET NEDERLANDS KANKER INSTITUUTANTONI VAN LEEUWENHOEK ZIEKENHUIS	2
STICHTING HUBRECHT ORGANOID TECHNOLOGY	2

Constancy:

Total number of partners: 803
Partner loyalty:
Frequent Partner: (> 2 projects): 281
Rare Partner: 522
Frequent / Rare Partner Ratio: 0.54

Project overview:

Start date	Project	acronym	role	funding	partners
2023-01-01	PhD Research and Innovation in Synchrotron Methods and Applications in Sweden	PRISMAS	participant	5.376.000	19
2023-01-01	From Caterpillar to BUTTERFLY: supporting transformation of DCs in a paediatric oncology network	Maxima Butterfly	participant	3.763.200	36
2022-09-01	Boosting the reduction of the environmental impact of pharmaceutical products throughout their entire life cycle.	ETERNAL	participant	5.922.396	16
2022-09-01	Gene Therapy of Rare Diseases	GetRadi	participant	2.785.810	14
2022-09-01	Assessing efficacy and safety of genome EDITing approaches for Sickle Cell Disease	EDITSCD	participant	6.001.250	8
2022-05-01	Next generation advanced RNA inhibition therapy to treat cardiometabolic disease	LiverTarget	participant	6.000.000	9
2022-01-01	FrAmework for ClInicaL trIal participants daTA reutilization for a fully Transparent and Ethical ecosystem	FACILITATE	participant	3.260.000	29
2021-11-01	Preparing for RSV Immunisation and Surveillance in Europe	PROMISE	participant	3.744.375	22
2021-10-01	Optimal treatment for patients with solid tumours in Europe through Artificial intelligence	OPTIMA	participant	10.459.997	39
2021-07-01	Building a reproducible single-cell experimental workflow to capture tumour drug persistence	PERSIST-SEQ	participant	7.057.980	16
2021-07-01	Real World Handling of Protein Drugs - Exploration, Evaluation and Education	RealHOPE	participant	3.139.984	27
2021-05-01	ENable LIGHT- and synthetic biology-driven volumetric bioprinting of functional human tissues	ENLIGHT	participant	3.594.925	8
2021-01-01	Boosting advanced doctoral training in innovative colon targeting drugs	COLOTAN	participant	3.533.108	10
2021-01-01	EU Training Network in understanding the molecular regulation and the role of endo-lysosomal processes in cardio-metabolic diseases	EndoConnect	participant	4.050.849	12
2021-01-01	Oligonucleotides for Medical Applications	OLIGOMED	participant	4.153.344	13
2021-01-01	Advanced machine learning for Innovative Drug Discovery	AIDD	participant	3.926.573	17
2021-01-01	A fully integrated, animal-free, end-to-end modelling approach to oral drug product development	InPharma	participant	3.464.964	11
2020-11-01	Gravitate–Health: Empowering and Equipping Europeans with health information for Active Personal Health Management and Adherence to Treatment	Gravitate-Health	participant	9.280.000	42
2020-10-01	H2O Health Outcomes Observatory	H2O	participant	10.476.687	25
2020-09-01	NExt ApplicationS of Quantum Computing	NEASQC	participant	4.671.333	15
2020-09-01	Prioritisation and Risk Evaluation of Medicines in the EnviRonment	PREMIER	participant	4.550.000	25
2020-07-01	C-H Activation for Industrial Renewal	CHAIR	participant	3.938.270	14
2020-02-01	Cooperation towards a sustainable chemical industry	CO2PERATE	participant	4.140.661	10
2020-01-01	PharmaLedger	PharmaLedger	participant	8.290.694	30
2020-01-01	Multidisciplinary Training in Chronic Kidney Disease: from genetic modifiers to drug discovery	TrainCKDis	participant	4.017.848	10
2019-11-01	Identifying Digital Endpoints to Assess FAtigue, Sleep and acTivities in daily living in Neurodegenerative disorders and Immune-mediated inflammatory diseases	IDEA-FAST	participant	20.997.523	47
2019-11-01	EU Patient- cEntric clinicAl tRial pLatform	EU-PEARL	participant	12.004.953	37
2019-10-01	PancREatic Cancer OrganoiDs rEsearch Network	PRECODE	participant	3.992.892	15
2019-09-01	Trials@Home: Center of Excellence – Remote Decentralised Clinical Trials	Trials@Home	participant	19.036.998	33
2019-09-01	EXpanding Platforms for Efficacious mRNA Therapeutics	EXPERT	participant	14.931.338	11
2019-09-01	Identification of the Molecular Mechanisms of non-response to Treatments, Relapses and Remission in Autoimmune, Inflammatory, and Allergic Conditions	3TR	participant	40.273.192	70
2019-06-01	MachinE Learning Ledger Orchestration for Drug DiscoverY	MELLODDY	participant	8.000.000	17
2019-05-01	Saracatinib Trial tO Prevent FOP	STOPFOP	participant	999.710	6
2019-05-01	Parkinson Disease with Mild cognition Impairment treated with Nicotinic agonist Drug	PD-MIND	participant	999.698	10
2019-05-01	INnate-ImmunomeTabolIsm as Antiviral TargEt	INITIATE	participant	4.054.106	14
2019-04-01	Connecting digital mobility assessment to clinical outcomes for regulatory and clinical endorsement	MOBILISE-D	participant	25.395.897	35
2019-03-01	Neurotoxicity De-Risking in Preclinical Drug Discovery	NeuroDeRisk	participant	5.331.000	18
2019-03-01	A multidisciplinary approach towards sustainable improvement in rare diseases care uniting Europe's top class vascular research to find new treatment strategies for vascular anomalies	V.A. Cure	participant	3.792.136	17
2019-01-01	FAIRplus	FAIRplus	participant	3.996.150	22
2019-01-01	Stirling heat pump for high temperature industrial use	Highlift	participant	2.439.512	3
2019-01-01	A European Training Network to Combat Bone Pain	BonePainII	participant	4.291.665	12

Alias institution names:

ASTRAZENECA

ASTRAZENECA - United Kingdom